WKN DE: A2QB6B / ISIN: US26818M1080

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Dyne Therapeutics Times and Sales (NAS)

Zeit	Kurs	Umsatz (Stk)
20:57:56	20,620	153
20:57:56	20,620	25
20:57:56	20,620	30
20:57:52	20,620	70
20:57:22	20,620	6
20:56:37	20,620	8
20:56:37	20,620	21
20:56:07	20,630	3
20:56:07	20,630	7
20:55:49	20,630	6
20:55:15	20,620	8
20:55:07	20,630	3
20:55:07	20,630	1
20:54:59	20,630	25
20:54:53	20,630	100
20:54:53	20,620	16
20:54:53	20,620	5
20:54:53	20,620	100
20:53:55	20,610	100
20:53:55	20,610	6
20:53:31	20,620	100
20:53:31	20,620	2
20:53:31	20,620	6
20:53:18	20,620	22
20:53:18	20,620	37
20:53:18	20,620	8
20:53:18	20,610	1
20:53:18	20,610	5
20:53:04	20,610	50
20:53:04	20,620	100
20:53:04	20,620	40
20:53:04	20,620	124
20:53:04	20,620	12
20:52:45	20,630	18
20:52:45	20,630	5

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Dyne Therapeutics Inc Registered Shs

Weitere Meldungen

20:45		VR Games Showcase Sommer 2026: „Transformers“ kommen auf die Meta Quest
20:40		Jazz Pharmaceuticals' Lung Cancer Drug Setback in Late-Stage Trials: Here's Why the Stock Impact May Be More Limited Than It Looks
20:31		The AI Trade Is Wobbling. Berkshire Hathaway Was Built for a Market Like This.
20:26		Here's Why Shares in GE Vernova Declined Today
20:24		Here’s Why Sterling Infrastructure Stock Can Keep Rallying From Here
20:23		SpaceX stock’s wild price swings since its IPO show how risky leveraged ETFs can be
20:23		Prediction: Sandisk Will Become a Trillion-Dollar Company by the End of 2027
20:19		Curacao's trailblazing doctor at the World Cup
20:15		Now That the IPO Has Passed, Here Are 5 Important Milestones SpaceX Investors Should Pay Attention to
20:13		Wall Street Tuesday: Dow Green, Nasdaq Bleeding, SpaceX Wild
20:03		Why Atlantic International (ATLN) Stock Is Up 175% On Tuesday
20:02		Mission Produce Director Buys $3.2 Million Shares. Is it Time to Invest in AVO?
20:02		Here's How Much You'd Need to Invest in HDV to Generate $500 per Month in Dividends
20:00		UK tax loophole used by Shein will not be closed until October 2028
20:00		3D-Drucker-Deals: Die besten Schnäppchen zum Prime Day - Bambu günstig wie nie
19:55		Anduril Lands Major Army Deal After 10 Months Of Battlefield Testing
19:52		As Investors Cool On The Magnificent Seven, Thornburg Debuts Dividend-And-Options ETF THOR
19:51		Meta halts worker tracking for AI training due to privacy fears
19:48		SpaceX pitches investors juicy yields in $25bn bond deal
19:48		SpaceX pitches investors juicy yields in $25bn bond deal
19:46		Sangamo Bankruptcy Puts Gene Therapy Platforms In Play, Eli Lilly And Astellas Circle
19:46		Lockheed Martin Stock Is Down 6% in 2 Days. Here's What Investors Need to Know
19:46		Here's Why Shares in Vertiv Crashed Today
19:45		SpaceX Saw 850,000 Orders From Robinhood For Its IPO: What's Going On?
19:45		Your index fund is hiding a looming tech-stock risk — here is how to protect your portfolio
19:41		Archer Aviation vs. Boeing: Is an Upstart or Established Aerospace Stock the Better Buy in 2026?
19:38		Elon Musk's Space Data Center Vision Is Uneconomical, Says SoftBank Founder Masayoshi Son
19:31		Qualcomm AI, Data Center Opportunity Fails To Win Over Analyst: Late Entrant In 'Hyper-Competitive AI Market’
19:31		Prediction: You Won't Recognize Enbridge in 15 Years. Here's Why.
19:29		Eli Lilly and Bayer hit out at Germany’s spending on new medicines
19:29		Eli Lilly and Bayer hit out at Germany’s spending on new medicines
19:26		SpaceX Is Pulling Back. These 3 Stocks Are the Biggest Beneficiaries.
19:25		US Supreme Court limits scope of foreign human rights claims
19:23		Why Bloom Energy Stock Tumbled Today
19:22		Why Royal Caribbean Stock Dropped, Then Popped
19:21		Carnival’s Record Quarter Gets Sunk By Middle East Worries
19:19		Ford and General Motors Want In on the Energy Craze. Which Stock Will Win?
19:11		AbbVie’s Costly Apogee Acquisition Has Long-Term Upside: Analyst
19:11		Adobe vs. Duolingo: Which Technology Stock Is a Better Buy in 2026?
19:04		Trump admits selling IBM’s stock was a mistake. Now he’s cheering its quantum future.
19:01		Nio Shares Edge Higher Tuesday: What's Going On?
18:59		Why Is Natera Stock Gaining Tuesday?
18:59		Interest Rates Are Likely to Rise This Year. Here's What That Could Mean for the S&P 500
18:48		SpaceX Dropped Sharply on Monday. Is It Worth Buying the Dip?
18:47		Stock Market Today, June 23: Sandisk Leads Tech Stock Slide as South Korea Jitters Trigger Global Pullback at Midday
18:47		SpaceX Stock Is Down 35% From Its Peak and Back Near Its IPO Price. Is It Time to Buy the Dip?
18:45		Here’s How Much You Would Have Made Owning State Street SPDR Portfolio S&P 500 Growth ETF Stock In The Last 15 Years
18:45		Chip Bloodbath Hits Nasdaq 100 As South Korea Plunges: Stock Market Today
18:39		Why Is AST SpaceMobile Stock Gaining Tuesday?
18:30		Here's How Much $100 Invested In Hims & Hers Health 5 Years Ago Would Be Worth Today

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Exploits Discovery NextEra Energy Stone Gold PMV Consumer Acquisition a Aton Resources

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	23.06.2026 21:12
Kaufwert:	EUR
	Hinzufügen Speichern

Dyne Therapeutics Aktie

WKN DE: A2QB6B / ISIN: US26818M1080

Dyne Therapeutics Times and Sales (NAS)

Analysen zu Dyne Therapeutics Inc Registered Shs

Weitere Meldungen